Prognostic value of MRD status after remission induction in distinct AML risk groups in context of MRD-guided consolidation treatment choice. RFS by MRD status after induction cycle 2 in favorable risk (A), intermediate risk (B), and adverse risk (C) 2017 ELN risk classification groups. The prognostic significance of MRD positivity is lost in intermediate-risk AML in the context of MRD-guided treatment choice.